AlphaCrest Capital Management LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2022$365,000
-44.6%
1,950
-51.9%
0.02%
-31.2%
Q2 2022$659,000
+50.8%
4,056
+74.4%
0.03%
+33.3%
Q1 2022$437,000
-63.1%
2,326
-48.0%
0.02%
-45.5%
Q4 2021$1,184,000
+164.3%
4,469
+188.1%
0.04%
+91.3%
Q3 2021$448,000
-46.8%
1,551
-63.2%
0.02%
-36.1%
Q2 2021$842,000
+107.4%
4,217
+101.8%
0.04%
+56.5%
Q1 2021$406,000
+19.4%
2,090
+17.8%
0.02%
-17.9%
Q4 2020$340,000
+69.2%
1,774
+30.2%
0.03%
+27.3%
Q3 2020$201,000
-57.1%
1,362
-73.1%
0.02%
-42.1%
Q4 2019$468,000
-1.9%
5,058
-18.6%
0.04%
+31.0%
Q3 2019$477,0006,2140.03%
Other shareholders
REPLIGEN CORP shareholders Q4 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders